查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842087

美国临床实验试验供应和物流市场：市场规模、份额和趋势分析（按服务、阶段、治疗领域和最终用途划分），细分市场预测（2025-2033 年）

U.S. Clinical Trials Supply And Logistics Market Size, Share & Trends Analysis Report By Service, By Phase, By Therapeutic Area, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国临床实验试验供应与物流市场摘要

据估计，美国临床实验试验供应和物流市场在 2024 年的价值为 14 亿美元，预计到 2033 年将达到 28.7 亿美元，2025 年至 2033 年的复合年增长率为 8.45%。

受肿瘤学、罕见疾病、细胞和基因治疗等创新治疗领域的研发活动的推动，市场正经历强劲成长。

此外，日益复杂的临床试验设计以及对病人安全和产品完整性日益严格的监管要求，都对复杂的供应链模式提出了更高的要求。同时，分散式临床临床实验和直接面向患者的运输方案的采用，凸显了灵活合规的物流网络的重要性。此外，製药和生物技术公司不断增加的投资，也推动了对高效包装、温控储存和物流服务的需求，这些对于及时进行临床试验至关重要。

此外，大多数临床临床实验（涵盖各个阶段）都得到了专业供应解决方案的支持，包括低温运输物流、对照药物采购、临床包装和退货管理。早期临床试验透过灵活的供应模式，有效管理时间紧迫的小批量药物分发；而大规模的III期临床试验则受益于完善的全球仓储网路。此外，生技药品、生物相似药和先进疗法的研发管线不断扩展，进一步推动了对超低温处理和专业运输解决方案的需求。随着临床实验规模和地理范围的扩大，供应和物流供应商在确保临床实验药物的持续供应方面发挥着至关重要的作用。他们透过最大限度地减少延误、确保合规性并提高试验效率，在促进市场扩张方面发挥着不可或缺的作用。

此外，现有市场参与企业正积极推行策略性倡议，例如收购、拓展服务以及投资数位化平台，以提高透明度和追踪能力。与申办者和合约委外研发机构(CRO) 的合作也在加速推进，各公司正致力于扩大在美国的低温运输能，以应对临床实验日益复杂化带来的挑战。预计这些因素将在预测期内推动市场成长。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国临床实验试验供应与物流市场：驱动因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场挑战
    • 市场机会
  • 科技情势
  • 定价模式分析
  • 研发支出分析（2018-2024）
  • 临床实验数量分析（2024 年）
  • 关税影响分析
  • 价值链分析
    • 供应趋势
    • 需求趋势
  • 市场分析工具
    • 波特五力分析
    • PESTEL分析与SWOT分析
    • 新冠疫情影响分析

第四章：美国临床实验试验供应与物流市场：按服务类型分類的估算与趋势分析

  • 美国临床实验试验供应与物流市场：细分仪表板（按服务分类）
  • 美国临床实验试验供应与物流市场：按服务类型分類的变化分析
  • 依服务年资（2021-2033）
  • 物流与配送
  • 储存/保留
  • 包装、标籤和匿名化
  • 製造业
  • 比较采购
  • 其他服务

第五章：美国临床实验试验供应与物流市场：依阶段分類的估算与趋势分析

  • 美国临床实验试验供应与物流市场：细分仪表板（按阶段划分）
  • 美国临床实验试验供应与物流市场：按阶段分類的销售分析
  • 爱别 (2021-2033)
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第六章美国临床实验试验供应和物流市场：按治疗领域分類的估计和趋势分析

  • 美国临床实验试验供应与物流市场：按治疗领域细分仪表板
  • 美国临床实验试验供应与物流市场：按治疗领域分類的销售分析
  • 依治疗领域划分（2021-2033 年）
  • 瘤
  • 心血管疾病
  • 呼吸系统疾病
  • 中枢神经系统和精神障碍
  • 其他的

第七章美国临床实验试验供应与物流市场：依最终用途分類的估算与趋势分析

  • 美国临床实验试验供应与物流市场：细分仪表板，依最终用途划分
  • 美国临床实验试验供应和物流市场：按最终用途分類的销售分析
  • 依最终用途划分（2021-2033 年）
  • 製药
  • 生技药品
  • 医疗设备

第八章 竞争情势

  • 参与企业
  • 市场分析（热力图分析，2024 年）
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • UPS Healthcare
    • Piramal Pharma Solutions
    • DHL
    • Parexel International
    • Almac Group
    • UDG Healthcare
    • FedEx
    • Catalent, Inc.
Product Code: GVR-4-68040-228-3

U.S. Clinical Trials Supply & Logistics Market Summary

The U.S. clinical trials supply and logistics market size was estimated at USD 1.40 billion in 2024 and is projected to reach USD 2.87 billion by 2033, growing at a CAGR of 8.45% from 2025 to 2033. The market has experienced robust growth driven by research and development activities for innovative therapeutic areas such as oncology, rare diseases, and cell and gene therapies.

Besides, the growing complexity of trial designs and regulatory requirements for patient safety and product integrity has led to the need for advanced supply chain models. Further, the adoption of decentralized trials and direct-to-patient delivery solutions has highlighted the significance of flexible and compliant logistics networks. In addition, increased investment from pharmaceutical and biotech companies has enhanced the demand for efficient packaging, temperature-controlled storage, and distribution services essential for timely trial execution.

Moreover, most clinical trials across various phases have been supported by specialized supply solutions such as cold chain distribution, comparator sourcing, clinical packaging, and return management. Smaller batch distributions with tight timelines have been effectively managed for early-phase studies through adaptable supply models, while large-scale Phase III trials benefit from comprehensive global depot networks. Besides, the expanding pipeline of biologics, biosimilars, and advanced therapies has further boosted the need for ultra-low temperature handling and specialized transportation solutions. As trials broaden in scope and geographical reach, supply and logistics providers have become crucial in ensuring the continuous availability of investigational products. Their role has been vital in fueling market expansion by minimizing delays, ensuring compliance, and enhancing trial efficiency.

Furthermore, established market players are pursuing strategic initiatives, including acquisitions, service expansions, and investments in digital platforms to enhance visibility and tracking. Collaborations with sponsors and contract research organizations (CROs) are being accelerated, focusing on increasing cold chain capacity in the U.S. to address the challenges posed by growing trial complexity. Such factors are expected to drive the market over the estimated timeframe.

U.S. Clinical Trials Supply And Logistics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. clinical trials supply & logistics market report based on service, phase, therapeutic area, and end-use.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Logistics & Distribution
  • Storage & Retention
  • Packaging, Labeling, and Blinding
  • Manufacturing
  • Comparator Sourcing
  • Other Services
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • CNS And Mental Disorders
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceuticals
  • Biologicals
  • Medical Device

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Phase
    • 1.2.3. Therapeutic Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Clinical Trials Supply & Logistics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements in Supply Chain
      • 3.2.1.2. Increasing R&D Investment by Pharmaceutical and Biopharmaceutical Firms
      • 3.2.1.3. Increasing Demand For Outsourcing Services Across The Developing Economies
      • 3.2.1.4. Expansion of Clinical Trial Sites
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent Regulation Pertaining to Logistics
      • 3.2.2.2. Counterfeiting of Drugs
    • 3.2.3. Market Challenges
    • 3.2.4. Market Opportunities
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. R&D Spending Analysis (2018-2024)
  • 3.6. Clinical Trial Volume Analysis, 2024
  • 3.7. Tariff Impact Analysis
  • 3.8. Value Chain Analysis
    • 3.8.1. Supply Trends
    • 3.8.2. Demand Trends
  • 3.9. Market Analysis Tools
    • 3.9.1. Porter's Five Force Analysis
    • 3.9.2. PESTEL by SWOT Analysis
    • 3.9.3. COVID-19 Impact Analysis

Chapter 4. U.S. Clinical Trials Supply & Logistics Market: Service Estimates & Trend Analysis

  • 4.1. U.S. Clinical Trials Supply & Logistics Market, By Service: Segment Dashboard
  • 4.2. U.S. Clinical Trials Supply & Logistics Market, By Service: Movement Analysis
  • 4.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 4.4. Logistics & Distribution
    • 4.4.1. Logistics & Distribution Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Storage & Retention
    • 4.5.1. Storage & Retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Packaging, Labeling, and Blinding
    • 4.6.1. Packaging, Labeling, and Blinding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Manufacturing
    • 4.7.1. Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Comparator Sourcing
    • 4.8.1. Comparator Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Other Services
    • 4.9.1. Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Clinical Trials Supply & Logistics Market: Phase Estimates & Trend Analysis

  • 5.1. U.S. Clinical Trials Supply & Logistics Market, By Phase: Segment Dashboard
  • 5.2. U.S. Clinical Trials Supply & Logistics Market, By Phase: Movement Analysis
  • 5.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By Phase, 2021 - 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. U.S. Clinical Trials Supply & Logistics Market, By Therapeutic Area: Segment Dashboard
  • 6.2. U.S. Clinical Trials Supply & Logistics Market, By Therapeutic Area: Movement Analysis
  • 6.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Cardiovascular Diseases
    • 6.5.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Respiratory Diseases
    • 6.6.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. CNS And Mental Disorders
    • 6.7.1. CNS And Mental Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Clinical Trials Supply & Logistics Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Clinical Trials Supply & Logistics Market, By End Use: Segment Dashboard
  • 7.2. U.S. Clinical Trials Supply & Logistics Market, By End Use: Movement Analysis
  • 7.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Pharmaceuticals
    • 7.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Biologicals
    • 7.5.1. Biologicals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Medical Device
    • 7.6.1. Medical Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Market Position Analysis, 2024 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. UPS Healthcare
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Piramal Pharma Solutions
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. DHL
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Parexel International
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Almac Group
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. UDG Healthcare
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. FedEx
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Catalent, Inc.
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
  • Table 5 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 6 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 U.S. Clinical Trials Supply & Logistics Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. Clinical Trials Supply & Logistics Market: Service outlook and key takeaways
  • Fig. 20 U.S. Clinical Trials Supply & Logistics Market: Service movement analysis
  • Fig. 21 Logistics & Distribution Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Storage & Retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Packaging, Labeling, and Blinding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Comparator Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Other Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Clinical Trials Supply & Logistics Market: Phase outlook and key takeaways
  • Fig. 28 U.S. Clinical Trials Supply & Logistics Market: Phase movement analysis
  • Fig. 29 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area outlook and key takeaways
  • Fig. 34 U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area movement analysis
  • Fig. 35 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 CNS And Mental Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Clinical Trials Supply & Logistics Market: End Use outlook and key takeaways
  • Fig. 41 U.S. Clinical Trials Supply & Logistics Market: End Use movement analysis
  • Fig. 42 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Biologicals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Medical Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key company categorization
  • Fig. 47 Service heat map analysis
  • Fig. 48 Strategic framework